UACC staff spotlight: Elizabeth (Liz) McPeak
From left, Alaina Krone, MS, Elizabeth McPeak, MPH, and Rachna Shroff, MD enjoy Clinical Trials Day with Wilbur Wildcat in 2022.
Elizabeth (Liz) McPeak, MPH, CCRP
Clinical Research Administrative Director
Clinical Trials Office
Number of years with UACC: 10 this September
Contributions at UACC
As a clinical research administrative director, McPeak oversee the operations of the Clinical Trials Office. The CTO is comprised of more than 65 staff members who are responsible for managing all aspects of clinical trials from activation and regulatory maintenance, to enrolling patients, reporting data, ensuring compliance with regulatory requirements and clinical trial finances. McPeak works closely with Rachna Shroff, MD, the associate director of UACC Clinical Investigations, and Charles Hsu, MD, medical director of the CTO, to ensure all clinical research teams are supported and have the tools needed to maintain robust portfolios of clinical trials for all disease types.
McPeak has worked in cancer research for her entire career, starting out as a research technician in a lab at Dana Farber Cancer Institute after college and later working as a clinical research coordinator at both the University of Michigan Cancer Center and Dana Farber. She started at UACC as a regulatory coordinator in 2014 and worked as a manager in the CTO before stepping into her current role.
Favorite part of being a clinical research administrative director at UACC
“One of my favorite parts of working at UACC is the incredible team I have the privilege of collaborating with every day. The dedication, expertise, and compassion of my colleagues in addition to our UACC leadership is truly inspiring. The shared commitment of advancing cancer research and improving patient care makes every challenge more manageable and every success more meaningful. The people I work with make my job rewarding and continually motivate me to give my best. I feel fortunate to be able to contribute to cutting edge research that has the potential to make a real difference in the lives of cancer patients with the support of such an amazing team.”